Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
flulaval (1 trial)
inactivated influenza vaccine (2 trials)
influenza vlp vaccine (2 trials)
Communicable Diseases (Phase 2)
Infections (Phase 2)
Influenza, Human (Phase 2)
Respiratory Tract Diseases (Phase 2)
Respiratory Tract Infections (Phase 2)
RNA Virus Infections (Phase 2)
Virus Diseases (Phase 2)
Trials (2 total)
Trial APIs (3 total)